Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.

International journal of molecular sciences - 7 Mar 2017

Dayde Delphine, Tanaka Ichidai, Jain Rekha, Tai Mei Chee, Taguchi Ayumu

Abstract excerpt

The standard of care in locally advanced rectal cancer is neoadjuvant chemoradiation (nCRT) followed by radical surgery. Response to nCRT varies among patients and pathological complete response is associated with better outcome. However, there is a lack of effective methods to select rectal cancer patients who would or would not have a benefit from nCRT. The utility of clinicopathological and radiological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metabolomics

Share to Neoadjuvant Therapy

Share to Proteome

Share to Proteomics

Share to Rectal Neoplasms

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 28272347
DOI: 10.3390/ijms18030573
PMCID: PMC5372589

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.PMID 28272347Read ↗

The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.Semantic proximity Read ↗

Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.Semantic proximity Read ↗

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.Semantic proximity Read ↗

Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and ChallengesSemantic proximity Read ↗

Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Semantic proximity Read ↗

Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancerSemantic proximity Read ↗

Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.Semantic proximity Read ↗

Prediction of response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.Semantic proximity Read ↗

Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer.Semantic proximity Read ↗

Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal CancerSemantic proximity Read ↗

Prognostic biomarkers in colorectal cancer: where do we stand?Semantic proximity Read ↗

Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.